Blue Water Life Science Advisors’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.8M | Sell |
439,047
-255,000
| -37% | -$13.3M | 18.09% | 3 |
|
|
2025
Q1 | $29.6M | Hold |
694,047
| – | – | 29.3% | 1 |
|
|
2024
Q4 | $21.2M | Buy |
694,047
+243,000
| +54% | +$7.42M | 18.77% | 2 |
|
|
2024
Q3 | $10.3M | Sell |
451,047
-120,000
| -21% | -$2.75M | 9.1% | 6 |
|
|
2024
Q2 | $16.5M | Hold |
571,047
| – | – | 16.04% | 2 |
|
|
2024
Q1 | $11.8M | Hold |
571,047
| – | – | 11.08% | 3 |
|
|
2023
Q4 | $15.4M | Sell |
571,047
-105,000
| -16% | -$2.84M | 13.53% | 3 |
|
|
2023
Q3 | $20M | Hold |
676,047
| – | – | 18.92% | 3 |
|
|
2023
Q2 | $24.2M | Buy |
676,047
+185,602
| +38% | +$6.64M | 16.34% | 3 |
|
|
2023
Q1 | $11.5M | Sell |
490,445
-378,000
| -44% | -$8.86M | 7.6% | 5 |
|
|
2022
Q4 | $23.6M | Sell |
868,445
-110,000
| -11% | -$2.99M | 15.87% | 2 |
|
|
2022
Q3 | $52.7M | Buy |
978,445
+144,300
| +17% | +$7.77M | 21.26% | 1 |
|
|
2022
Q2 | $33.6M | Buy |
834,145
+172,700
| +26% | +$6.97M | 18.27% | 1 |
|
|
2022
Q1 | $43.8M | Buy |
661,445
+270,500
| +69% | +$17.9M | 20.79% | 2 |
|
|
2021
Q4 | $39.1M | Buy |
390,945
+264,121
| +208% | +$26.4M | 11.96% | 3 |
|
|
2021
Q3 | $15.9M | Sell |
126,824
-103,771
| -45% | -$13M | 5.16% | 8 |
|
|
2021
Q2 | $28.6M | Buy |
230,595
+45,265
| +24% | +$5.62M | 10.78% | 6 |
|
|
2021
Q1 | $28.3M | Buy |
185,330
+44,430
| +32% | +$6.78M | 13.82% | 4 |
|
|
2020
Q4 | $18.2M | Buy |
+140,900
| New | +$18.2M | 10.66% | 3 |
|